Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11389256 | 0.78 | ALDH1A1 (0.36) | CYP3A4L3MBTL1TSHRALDH1A1MAPK1 | |
| SCHEMBL29746097 | 0.76 | ALDH1A1 (0.44) | SRCCYP3A4L3MBTL1TSHRALDH1A1 | |
| SCHEMBL5936012 | 0.76 | ALDH1A1 (0.44) | SRCCYP3A4L3MBTL1TSHRALDH1A1 | |
| SCHEMBL456733 | 0.76 | SRC (0.45) | SRCCYP3A4TSHRHTTTDP1 | |
| Phosphoric Acid SCHEMBL4712956 | 0.75 | L3MBTL1 (0.44) | CYP3A4L3MBTL1TSHRALDH1A1MAPK1 | |
| SCHEMBL17491584 | 0.74 | CYP3A4 (0.37) | CYP3A4L3MBTL1TSHRALDH1A1MAPK1 | |
| Phosphoric Acid SCHEMBL4710580 | 0.74 | ALDH1A1 (0.35) | CYP3A4L3MBTL1TSHRALDH1A1MAPK1 | |
| SCHEMBL451642 | 0.73 | TSHR (0.39) | CYP3A4L3MBTL1TSHRALDH1A1CA2 | |
| SCHEMBL29536728 | 0.73 | TSHR (0.39) | CYP3A4L3MBTL1TSHRALDH1A1CA2 | |
| SCHEMBL3673431 | 0.73 | S1PR1 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 268 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070149661-A1 | POLYCARBONATE COMPOSITION, METHOD OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME | CITIBANK, N.A., AS COLLATERAL AGENT | 2007-06-28 | — | — | US | claimed |
| US-12570848-B2 | Scratch-resistant high impact strength PMMA compositions | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2026-03-10 | — | — | US | disclosed |
| US-12403437-B2 | Method for producing nanodiamonds doped with group 14 element, and method for purifying same | DAICEL CORPORATION (JP) | 2025-09-02 | — | — | US | disclosed |
| US-12351463-B2 | Heteroatom-doped nanodiamond | DAICEL CORPORATION (JP) | 2025-07-08 | — | — | US | disclosed |
| EP-4172269-B1 | THERMOPLASTIC COMPOSITIONS WITH IMPROVED HYDROLYTIC AND HEAT STABILITY | SHPP GLOBAL TECH BV (NL) | 2025-05-28 | — | — | EP | disclosed |
| WO-2025104593-A1 | PFAS-FREE FLAME RETARDANT, IMPACT RESISTANT AND CHEMICAL RESISTANT POLYCARBONATE COMPOSITIONS | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2025-05-22 | — | — | WO | disclosed |
| US-20250002355-A1 | HETEROATOM-DOPED NANODIAMOND PARTICLES AND METHOD FOR PRODUCING HETEROATOM-DOPED NANODIAMOND PARTICLES | DAICEL CORPORATION (JP) | 2025-01-02 | — | — | US | disclosed |
| WO-2024219059-A1 | NV CENTER-CONTAINING NANODIAMOND PARTICLE AND METHOD FOR PRODUCING SAME | 株式会社ダイセル | 2024-10-24 | — | — | WO | disclosed |
| EP-3390469-B1 | METHOD FOR ISOMER REDUCTION DURING POLYMERIZATION AND SYSTEM FOR ACCOMPLISHING THE SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-09-04 | — | — | EP | disclosed |
| WO-2024135735-A1 | FOAM MOLDING COMPOSITION, FOAM-MOLDED BODY, FOAMED ELECTRIC WIRE, MANUFACTURING METHOD FOR FOAM-MOLDED BODY, MANUFACTURING METHOD FOR ELECTRIC WIRE, AND IN-VEHICLE NETWORK CABLE | ダイキン工業株式会社 | 2024-06-27 | — | — | WO | disclosed |
| US-4794137-A | POLYPHENYLENE ETHER, AROMATIC PHOSPHATE, DIVINYL BENZENE | GENERAL ELECTRIC COMPANY (US) | 1988-12-27 | — | — | US | disclosed |
| EP-0229498-A1 | Thermoplastic resin composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-07-22 | — | — | EP | disclosed |
| EP-0212684-A1 | Thermoplastic polymer mixture comprising polyfunctional diene compound | GENERAL ELECTRIC COMPANY (US) | 1987-03-04 | — | — | EP | disclosed |
| EP-0055473-B1 | RESIN COMPOSITIONS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1986-04-09 | — | — | EP | disclosed |
| EP-0146104-A2 | Polyester thermoplastic molding compositions with good mold release | MOBAY CORPORATION (US) | 1985-06-26 | — | — | EP | disclosed |
| EP-0055473-A1 | Resin compositions | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-07-07 | — | — | EP | disclosed |
| US-4254011-A | CONTAINING A TWO-PHASE CROSSLINKED POLYACRYLATE | BAYER AKTIENGESELLSCHAFT (DE) | 1981-03-03 | — | — | US | disclosed |
| US-4136089-A | 2,2-DIETHYL-PROPANE-1,3-DIOL | BAYER AKTIENGESELLSCHAFT (DE) | 1979-01-23 | — | — | US | disclosed |
| US-4107149-A | Poly(ethylene/alkylene) terephthalates which crystallize rapidly | BAYER AKTIENGESELLSCHAFT (DE) | 1978-08-15 | — | — | US | disclosed |
| US-4086212-A | ESTERIFICATION OR TRANSESTERIFICATION | BAYER AKTIENGESELLSCHAFT (DT) | 1978-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570848-B2 | Scratch-resistant high impact strength PMMA compositions | PCNA, COL2A1, COL1A1 | SRC 1022/4885CYP3A4 3771/4885L3MBTL1 1383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.